Colorectal Cancer Dataset in Xijing Hospital From 2011
NCT06308354 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40000
Last updated 2024-03-13
Summary
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
Conditions
- Prognostic Cancer Model
- Chemotherapy
- Nutrition Related Cancer
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-01
- Primary Completion
- 2048-01-01
- Completion
- 2048-01-01
Countries
- China
Study Locations
More Related Trials
-
Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp
NCT05638542 ·Status: ACTIVE_NOT_RECRUITING
-
Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer
NCT06584318 ·Status: RECRUITING ·Phase: NA
-
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT05365412 ·Status: RECRUITING
-
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
NCT06977373 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PET-CT and Circulating Tumor Cells in Colorectal Cancer
NCT01163305 ·Status: COMPLETED
-
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 ·Status: RECRUITING
-
CRC Post-surgical Assessment and Recurrence Monitoring
NCT03334890 ·Status: UNKNOWN
-
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
NCT03794193 ·Status: UNKNOWN
-
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
NCT04835324 ·Status: UNKNOWN
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
PTC Drug Sensitivity Detection to Guide Postoperative Adjuvant of Colorectal Cancer
NCT05978349 ·Status: UNKNOWN ·Phase: NA
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
NCT03038217 ·Status: UNKNOWN ·Phase: PHASE3
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
NCT07333651 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
NCT05635149 ·Status: UNKNOWN
-
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
NCT06903325 ·Status: RECRUITING
-
Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy
NCT04333004 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer
NCT05414461 ·Status: COMPLETED ·Phase: PHASE2
-
Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients
NCT03030508 ·Status: UNKNOWN
-
Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
NCT06637215 ·Status: RECRUITING ·Phase: NA
-
Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer
NCT07333053 ·Status: RECRUITING ·Phase: NA
-
Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
NCT06115837 ·Status: COMPLETED
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis
NCT03031444 ·Status: COMPLETED ·Phase: PHASE2/PHASE3